BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene

Pigment Cell and Melanoma Research

Volumn 26, Issue 3, 2013, Pages 377-391

  Saladi, Srinivas V ^a,c   Wong, Philip G ^a   Trivedi, Archit R ^a   Marathe, Himangi G ^a   Keenen, Bridget ^a   Aras, Shweta ^a   Liew, Zi Qi ^a   Setaluri, Vijayasaradhi ^b   de la Serna, Ivana L ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Apoptosis; Chromatin remodeling; Melanoma; MITF; ML IAP; SWI SNF enzymes; Ultraviolet radiation

Indexed keywords

BAF 180 PROTEIN; BRG1 PROTEIN; CELL ENZYME; DNA; LIVIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; NUCLEIC ACID BINDING PROTEIN; SNF ENZYME; SWI ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL DEATH; CELL LINEAGE; CELL PROTECTION; CELL SURVIVAL; CHROMATIN STRUCTURE; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION; MELANOMA CELL; PROTEIN FUNCTION; ULTRAVIOLET IRRADIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATIN; CYTOPROTECTION; DNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MELANOMA; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ULTRAVIOLET RAYS;

EID: 84876795610     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12088     Document Type: Article

References (45)

1. Bowen, A.R., Hanks, A.N., Allen, S.M., Alexander, A., Diedrich, M.J., and Grossman, D. (2003). Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J. Invest. Dermatol. 120, 48-55.
2. Burrows, A.E., Smogorzewska, A., and Elledge, S.J. (2010). Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc. Natl Acad. Sci. USA 107, 14280-14285.
3. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L., and Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426-3439.
4. Crnkovic-Mertens, I., Hoppe-Seyler, F., and Butz, K. (2003). Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 22, 8330-8336.
5. Crnkovic-Mertens, I., Semzow, J., Hoppe-Seyler, F., and Butz, K. (2006). Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells. J. Mol. Med. 84, 232-240.
6. Cruickshank, M., Fenwick, E., Abraham, L.J., and Ulgiati, D. (2008). Quantitative differences in chromatin accessibility across regulatory regions can be directly compared in distinct cell-types. Biochem. Biophys. Res. Commun. 367, 349-355.
7. Decristofaro, M.F., Betz, B.L., Rorie, C.J., Reisman, D.N., Wang, W., and Weissman, B.E. (2001). Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J. Cell. Physiol. 186, 136-145.
8. Dynek, J.N., Chan, S.M., Liu, J., Zha, J., Fairbrother, W.J., and Vucic, D. (2008). Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res. 68, 3124-3132.
9. Flowers, S., Nagl, N.G. Jr, Beck, G.R. Jr, and Moran, E. (2009). Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. J. Biol. Chem. 284, 10067-10075.
10. Flygare, J.A., Beresini, M., Budha, N. et al. (2012). Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J. Med. Chem. 55, 4101-4113.
11. Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122.
12. Gupta, P.B., Kuperwasser, C., Brunet, J.P., Ramaswamy, S., Kuo, W.L., Gray, J.W., Naber, S.P., and Weinberg, R.A. (2005). The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat. Genet. 37, 1047-1054.
13. Hodis, E., Watson, I.R., Kryukov, G.V. et al. (2012). A landscape of driver mutations in melanoma. Cell 150, 251-263.
14. Hornyak, T.J., Jiang, S., Guzman, E.A., Scissors, B.N., Tuchinda, C., He, H., Neville, J.D., and Strickland, F.M. (2009). Mitf dosage as a primary determinant of melanocyte survival after ultraviolet irradiation. Pigment Cell Melanoma Res. 22, 307-318.
15. Jhappan, C., Noonan, F.P., and Merlino, G. (2003). Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22, 3099-3112.
16. Kasof, G.M., and Gomes, B.C. (2001). Livin, a novel inhibitor of apoptosis protein family member. J. Biol. Chem. 276, 3238-3246.
17. Keenen, B., Qi, H., Saladi, S.V., Yeung, M., and de la Serna, I.L. (2010). Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma. Oncogene 29, 81-92.
18. Kia, S.K., Gorski, M.M., Giannakopoulos, S., and Verrijzer, C.P. (2008). SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol. Cell. Biol. 28, 3457-3464.
19. Kothandapani, A., Gopalakrishnan, K., Kahali, B., Reisman, D., and Patrick, S.M. (2012). Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Exp. Cell Res. 318, 1973-1986.
20. Krauthammer, M., Kong, Y., Ha, B.H. et al. (2012). Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet. 44, 1006-1014.
21. Lazar, I., Perlman, R., Lotem, M., Peretz, T., Ben-Yehuda, D., and Kadouri, L. (2012). The clinical effect of the inhibitor of apopotosis protein livin in melanoma. Oncology 82, 197-204.
22. Lin, H., Wong, R.P., Martinka, M., and Li, G. (2010). BRG1 expression is increased in human cutaneous melanoma. Br. J. Dermatol. 163, 502-510.
23. Liu, T.F., Kandala, G., andSetaluri, V. (2001). PDZ domain protein GIPC interacts with the cytoplasmic tail of melanosomal membrane protein gp75 (tyrosinase-related protein-1). J. Biol. Chem. 276, 35768-35777.
24. Liu, B., Han, M., Wen, J.K., and Wang, L. (2007). Livin/ML-IAP as a new target for cancer treatment. Cancer Lett. 250, 168-176.
25. Liu, F., Fu, Y., and Meyskens, F.L. Jr. (2009). MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J. Invest. Dermatol. 129, 422-431.
26. McGill, G.G., Horstmann, M., Widlund, H.R. et al. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718.
27. O'Riordan, M.X., Bauler, L.D., Scott, F.L., and Duckett, C.S. (2008). Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation. Dev. Cell 15, 497-508.
28. Ozsolak, F., Song, J.S., Liu, X.S., and Fisher, D.E. (2007). High-throughput mapping of the chromatin structure of human promoters. Nat. Biotechnol. 25, 244-248.
29. Rao, S., Procko, E., and Shannon, M.F. (2001). Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol. 167, 4494-4503.
30. Rouzaud, F., Kadekaro, A.L., Abdel-Malek, Z.A., and Hearing, V.J. (2005). MC1R and the response of melanocytes to ultraviolet radiation. Mutat. Res. 571, 133-152.
31. Saladi, S.V., Keenen, B., Marathe, H.G., Qi, H., Chin, K.V., and de la Serna, I.L. (2010). Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness. Mol. Cancer 9, 280-297.
32. Sato, S., Roberts, K., Gambino, G., Cook, A., Kouzarides, T., and Goding, C.R. (1997). CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene 14, 3083-3092.
33. de la Serna, I.L., Carlson, K.A., Hill, D.A., Guidi, C.J., Stephenson, R.O., Sif, S., Kingston, R.E., and Imbalzano, A.N. (2000). Mammalian SWI-SNF complexes contribute to activation of the hsp70 gene. Mol. Cell. Biol. 20, 2839-2851.
34. de la Serna, I.L., Ohkawa, Y., Higashi, C., Dutta, C., Osias, J., Kommajosyula, N., Tachibana, T., and Imbalzano, A.N. (2006a). The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. J. Biol. Chem. 281, 20233-20241.
35. de la Serna, I.L., Ohkawa, Y., and Imbalzano, A.N. (2006b). Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat. Rev. Genet. 7, 461-473.
36. Sviderskaya, E.V., Hill, S.P., Balachandar, D., Barsh, G.S., and Bennett, D.C. (2001). Agouti signaling protein and other factors modulating differentiation and proliferation of immortal melanoblasts. Dev. Dyn. 221, 373-379.
37. Varela, I., Tarpey, P., Raine, K. et al. (2011). Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539-542.
38. Varfolomeev, E., Moradi, E., Dynek, J.N., Zha, J., Fedorova, A.V., Deshayes, K., Fairbrother, W.J., Newton, K., Le Couter, J., and Vucic, D. (2012). Characterization of ML-IAP protein stability and physiological role in vivo. Biochem. J. 447, 427-436.
39. Vucic, D., Stennicke, H.R., Pisabarro, M.T., Salvesen, G.S., and Dixit, V.M. (2000). ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr. Biol. 10, 1359-1366.
40. Wilson, B.G., Wang, X., Shen, X., McKenna, E.S., Lemieux, M.E., Cho, Y.J., Koellhoffer, E.C., Pomeroy, S.L., Orkin, S.H., and Roberts, C.W. (2010). Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 18, 316-328.
41. Xia, W., Nagase, S., Montia, A.G., Kalachikov, S.M., Keniry, M., Su, T., Memeo, L., Hibshoosh, H., and Parsons, R. (2008). BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer. Cancer Res. 68, 1667-1674.
42. Xu, Y., Zhang, J., and Chen, X. (2007). The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes. J. Biol. Chem. 282, 37429-37435.
43. Yan, Z., Cui, K., Murray, D.M., Ling, C., Xue, Y., Gerstein, A., Parsons, R., Zhao, K., and Wang, W. (2005). PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev. 19, 1662-1667.
44. Ye, L., Song, X., Li, S., Yang, D., Zhang, J., Che, X., Chen, X., Wang, J., and Zhang, Z. (2011). Livin-alpha promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer. Prostate 71, 42-51.
45. Zhao, Q., Wang, Q.E., Ray, A., Wani, G., Han, C., Milum, K., and Wani, A.A. (2009). Modulation of nucleotide excision repair by mammalian SWI/SNF chromatin-remodeling complex. J. Biol. Chem. 284, 30424-30432.